Cellular Goods to launch skin care formulated with Willow CBG this fall Today, the UK-based cannabinoid consumer goods venture and Willow Biosciences out of Vancouver, Columbia, Canada, announced a multi-year supply deal.
Just last month Willow Biosciences presented data on the skin care benefits of its biotech CBG at the Society for Investigative Dermatology’s annual meeting. The company’s data shows that CBG inhibits UV light and cytokine release triggered by C. acnes as well as that the ingredient acts as an antimicrobial and has antioxidant properties, as Cosmetics Design reported.
Now Willow Biosciences has reached another milestone on the journey to commercializing their biotech beauty ingredient:
/CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF), a Canadian biotechnology company that manufactures ultra-pure,.
Global Investments Capital Corp. Announces Annual General and Special Meeting to Adopt and Align the Company with the New CPC Policy
TSXV: GLIN.P) (
TSXV or the
Exchange ), announces that, pursuant to recent changes by the TSXV to its Capital Pool Company program and TSXV Policy 2.4 -
Capital Pool Companies (
Policy 2.4 ), which became effective as at January 1, 2021 (the
New CPC Policy ), Global intends to seek the requisite approvals of the shareholders of Global (the
Shareholders ) to adopt and align the Company with the New CPC Policy at its June 16, 2021 Annual General and Special Meeting of Shareholders (the
Meeting ).
Capitalized terms used herein and not otherwise defined have the meaning ascribed to them in the TSXV Corporate Finance Manual or the New CPC Policy.
Willow Biosciences Added to NYSE-Listed Cannabis ETF THCX prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.